Adverse events associated with prescription drug cost-sharing among poor and elderly persons.
about
Pharmaceutical policies: effects of policies that determine which drugs are reimbursedPharmaceutical policies: effects of cap and co-payment on rational use of medicinesReminder packaging for improving adherence to self-administered long-term medicationsPharmaceutical policies: effects of cap and co-payment on rational drug useReminder packaging for improving adherence to self-administered long-term medicationsHealth insurance and mortality in US adultsCardiovascular comorbidities among public health clinic patients with diabetes: the Urban Diabetics StudyThe effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysisAssessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)-study protocol for a 2×2 factorial randomized trial.Medicaid prescription limits: policy trends and comparative impact on utilization.Physician awareness of drug cost: a systematic reviewDo randomized controlled trials discuss healthcare costs?Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gapA systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and developmentUsing decision support for population tracking of adherence to recommended asthma guidelinesUnintended consequences of delisting routine eye exams on retinopathy screening for people with diabetes in Ontario, CanadaAdverse drug event reporting systems: a systematic reviewThe effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial.Affordability of health care under publicly subsidized insurance after Massachusetts health care reform: a qualitative study of safety net patients.Health Insurance Status as a Barrier to Ideal Cardiovascular Health for U.S. Adults: Data from the National Health and Nutrition Examination Survey (NHANES).Assessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.Identifying patients with cost-related medication non-adherence: a big-data approachImpact of prescription size on statin adherence and cholesterol levelsInfluence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.Using patent data to assess the value of pharmaceutical innovation.Income-related differences in mortality among people with diabetes mellitusCosts and benefits of free medications after myocardial infarction.Regional socioeconomic disparities in outcomes for workers with low back pain in the United States.Impact of income-based deductibles on drug use and health care utilization among older adults.The effect of Medicare Part D on drug and medical spending.Drug company-sponsored patient assistance programs: a viable safety net?The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patientsReference drug programs: effectiveness and policy implications.The impact of cost sharing on antidepressant use among older adults in British Columbia.Impact of prescription benefit coverage limits on sevelamer hydrochloride adherence for patients with ESRD.Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers.Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization.Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.A new measure of medication affordability
P2860
Q24187567-8E246EEB-9761-470B-9A61-18D6CD41FD22Q24188009-5EC5B53E-75A4-4E41-8974-42FF5E00A25FQ24234452-FCB24952-98E3-405A-9900-77FFE0B15675Q24242490-DA1381EB-91BC-4573-AE67-88D8394646A7Q24244509-B024A25D-B8E7-474A-83C8-ACEAA95FFB78Q24658120-9B512839-77F8-4F56-B02C-D2C583293D6BQ24795220-32C33FF9-A02A-4E80-BD86-31DE3B1DCBA6Q26829072-3645504F-C4E5-4D31-9679-E95DE28DECD3Q27301465-B8FA45F8-76FA-46DE-A645-3784CBBB9FEDQ27306989-06F820F9-DD76-4F2A-9AB1-18E021ADBFDBQ28469310-61E243B2-1DD8-4EF5-8D27-8ACF1AE9F430Q28475247-E902C3E9-5E85-40CF-B969-1936BE6CEB2AQ28476575-5B87D03C-40CA-46EA-B797-63BF4E9F9D0DQ28540727-466976A6-A57B-4899-A9D5-E5371D25E342Q28657963-C4978177-8561-4C99-BFEA-3BC33271F04DQ28708791-8B8ABBA8-1DB4-4AF5-A655-C683E6520034Q30251709-80056FD7-E53D-42E5-8E70-FEAE0794BEBBQ30481376-849D78E6-8B26-456D-B55E-7FE253969145Q30671106-9368D9AD-E5D6-45F9-A755-F8D33505F279Q31017552-3C012527-A1C1-4970-97D2-EF05371B9032Q31060705-9EC0751D-3558-41E3-8630-9FEE0907A93AQ31070358-A7758C12-DA6B-4D06-B8B3-2ABD2E0744E3Q33303944-DEADC7E9-980F-4BD1-9191-150D2890705AQ33321951-E8EACA46-6461-40B7-A26E-DAEFCEF0F100Q33355816-BFE94158-38E4-4C95-9F9E-E3DED00386DCQ33459435-A918537D-4CF6-45ED-9BBE-58398EDD5B8FQ33575509-2B47ADFC-F936-4AAB-A55F-D8F42943F212Q33585275-7E68773C-1AEE-46E4-A7E8-599C10FB381BQ33628709-7958204E-982D-4C3F-B3DC-B63EFC24171DQ33694182-79976039-53EE-441D-BBA2-5C53FD6D0716Q33810332-E87E967E-DAB5-4C16-86A3-E2D9C3DA85A3Q33864928-81FD694D-2389-42AA-8034-23E5B8F7BA04Q33895340-015110B3-4BF7-4327-A787-24E3E9FFF09EQ33908085-AB210B10-D471-4DD1-A6CE-38A14C647C31Q33908092-7B24A849-8BC1-475F-A2E6-3580F6DB3E45Q33931931-004930AF-0911-419C-9BA5-0C4F638B303FQ33932255-27485271-BCDD-4E06-951A-B2F0AF6445E0Q33932355-AAD90E87-F33C-474E-B1FF-899477A038CFQ33942027-5F5C082B-97FF-4DFB-BB05-3F54D9441C67Q33945830-45B0BE9D-EAFA-49D9-B490-0AF6C3BF754E
P2860
Adverse events associated with prescription drug cost-sharing among poor and elderly persons.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Adverse events associated with ...... mong poor and elderly persons.
@en
Adverse events associated with ...... mong poor and elderly persons.
@nl
type
label
Adverse events associated with ...... mong poor and elderly persons.
@en
Adverse events associated with ...... mong poor and elderly persons.
@nl
prefLabel
Adverse events associated with ...... mong poor and elderly persons.
@en
Adverse events associated with ...... mong poor and elderly persons.
@nl
P2093
P356
P1476
Adverse events associated with ...... mong poor and elderly persons.
@en
P2093
J A Hanley
P Larochelle
P304
P356
10.1001/JAMA.285.4.421
P407
P577
2001-01-01T00:00:00Z